InvestorsHub Logo
Followers 17
Posts 987
Boards Moderated 0
Alias Born 01/24/2013

Re: loanranger post# 76150

Thursday, 10/30/2014 8:43:42 PM

Thursday, October 30, 2014 8:43:42 PM

Post# of 403528
I think this all smells of a deal. Leo needs some shares at the ready to structure it just right. In fact, I believe the deal is specific for B.

Take a look at the company description from the last few press releases:

– Cellceutix Corporation (OTCQB: CTIX) (the “Company”), a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology and antibiotic applications.

Now look at the "Our Company" description from the S-3, there is no mention of antibiotics and autism and inflammatory disease is added:

"We are a clinical stage developmental biotechnology pharmaceutical company focused on discovering small molecule drugs for hard to treat diseases, including drug-resistant cancers, psoriasis, autism and inflammatory disease"

CTIX can sell or partner b and focus on "autism and inflammatory disease".

My two cents! GO CTIX!!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News